BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 17762496)

  • 1. High expressions of neuronatin isoforms in favorable neuroblastoma.
    Higashi M; Tajiri T; Kinoshita Y; Tatsuta K; Souzaki R; Maehara Y; Suita S; Taguchi T
    J Pediatr Hematol Oncol; 2007 Aug; 29(8):551-6. PubMed ID: 17762496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-resolution analysis of 3p deletion in neuroblastoma and differential methylation of the SEMA3B tumor suppressor gene.
    Nair PN; McArdle L; Cornell J; Cohn SL; Stallings RL
    Cancer Genet Cytogenet; 2007 Apr; 174(2):100-10. PubMed ID: 17452250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide analysis in a murine Dnmt1 knockdown model identifies epigenetically silenced genes in primary human pituitary tumors.
    Dudley KJ; Revill K; Whitby P; Clayton RN; Farrell WE
    Mol Cancer Res; 2008 Oct; 6(10):1567-74. PubMed ID: 18922972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and functional analysis of neuronatin in mice with maternal or paternal duplication of distal Chr 2.
    Kikyo N; Williamson CM; John RM; Barton SC; Beechey CV; Ball ST; Cattanach BM; Surani MA; Peters J
    Dev Biol; 1997 Oct; 190(1):66-77. PubMed ID: 9331332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuron navigator 3 alterations in nervous system tumors associate with tumor malignancy grade and prognosis.
    Carlsson E; Krohn K; Ovaska K; Lindberg P; Häyry V; Maliniemi P; Lintulahti A; Korja M; Kivisaari R; Hussein S; Sarna S; Niiranen K; Hautaniemi S; Haapasalo H; Ranki A
    Genes Chromosomes Cancer; 2013 Feb; 52(2):191-201. PubMed ID: 23097141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of the novel endothelin-converting enzyme genes, Nbla03145/ECEL1alpha and beta, is associated with favorable prognosis in human neuroblastomas.
    Kawamoto T; Ohira M; Hamano S; Hori T; Nakagawara A
    Int J Oncol; 2003 Apr; 22(4):815-22. PubMed ID: 12632073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression profiling of favorable and unfavorable neuroblastomas.
    Hiyama E; Hiyama K; Yamaoka H; Sueda T; Reynolds CP; Yokoyama T
    Pediatr Surg Int; 2004 Jan; 20(1):33-8. PubMed ID: 14691637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the tumour suppressor gene CADM1 is associated with favourable outcome and inhibits cell survival in neuroblastoma.
    Nowacki S; Skowron M; Oberthuer A; Fagin A; Voth H; Brors B; Westermann F; Eggert A; Hero B; Berthold F; Fischer M
    Oncogene; 2008 May; 27(23):3329-38. PubMed ID: 18084322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of neuronatin expression is associated with promoter hypermethylation in pituitary adenoma.
    Revill K; Dudley KJ; Clayton RN; McNicol AM; Farrell WE
    Endocr Relat Cancer; 2009 Jun; 16(2):537-48. PubMed ID: 19218280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel human neuronal leucine-rich repeat (hNLRR) family genes and inverse association of expression of Nbla10449/hNLRR-1 and Nbla10677/hNLRR-3 with the prognosis of primary neuroblastomas.
    Hamano S; Ohira M; Isogai E; Nakada K; Nakagawara A
    Int J Oncol; 2004 Jun; 24(6):1457-66. PubMed ID: 15138588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation-associated silencing of the nuclear receptor 1I2 gene in advanced-type neuroblastomas, identified by bacterial artificial chromosome array-based methylated CpG island amplification.
    Misawa A; Inoue J; Sugino Y; Hosoi H; Sugimoto T; Hosoda F; Ohki M; Imoto I; Inazawa J
    Cancer Res; 2005 Nov; 65(22):10233-42. PubMed ID: 16288011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imprinted expression of neuronatin from modified BAC transgenes reveals regulation by distinct and distant enhancers.
    John RM; Aparicio SA; Ainscough JF; Arney KL; Khosla S; Hawker K; Hilton KJ; Barton SC; Surani MA
    Dev Biol; 2001 Aug; 236(2):387-99. PubMed ID: 11476579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neuronatin gene resides in a "micro-imprinted" domain on human chromosome 20q11.2.
    Evans HK; Wylie AA; Murphy SK; Jirtle RL
    Genomics; 2001 Sep; 77(1-2):99-104. PubMed ID: 11543638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation-associated silencing of the heat shock protein 47 gene in human neuroblastoma.
    Yang Q; Liu S; Tian Y; Hasan C; Kersey D; Salwen HR; Chlenski A; Perlman EJ; Cohn SL
    Cancer Res; 2004 Jul; 64(13):4531-8. PubMed ID: 15231663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HMGI(Y) and HMGI-C genes are expressed in neuroblastoma cell lines and tumors and affect retinoic acid responsiveness.
    Giannini G; Di Marcotullio L; Ristori E; Zani M; Crescenzi M; Scarpa S; Piaggio G; Vacca A; Peverali FA; Diana F; Screpanti I; Frati L; Gulino A
    Cancer Res; 1999 May; 59(10):2484-92. PubMed ID: 10344762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Favorable neuroblastoma genes and molecular therapeutics of neuroblastoma.
    Tang XX; Robinson ME; Riceberg JS; Kim DY; Kung B; Titus TB; Hayashi S; Flake AW; Carpentieri D; Ikegaki N
    Clin Cancer Res; 2004 Sep; 10(17):5837-44. PubMed ID: 15355914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of B-myb in neuroblastoma tumors is a poor prognostic factor independent from MYCN amplification.
    RaschellĂ  G; Cesi V; Amendola R; Negroni A; Tanno B; Altavista P; Tonini GP; De Bernardi B; Calabretta B
    Cancer Res; 1999 Jul; 59(14):3365-8. PubMed ID: 10416595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The p16 (CDKN2A) gene is involved in the growth of neuroblastoma cells and its expression is associated with prognosis of neuroblastoma patients.
    Takita J; Hayashi Y; Nakajima T; Adachi J; Tanaka T; Yamaguchi N; Ogawa Y; Hanada R; Yamamoto K; Yokota J
    Oncogene; 1998 Dec; 17(24):3137-43. PubMed ID: 9872329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caspase-8 gene expression in neuroblastoma.
    Casciano I; Banelli B; Croce M; De Ambrosis A; di Vinci A; Gelvi I; Pagnan G; Brignole C; Allemanni G; Ferrini S; Ponzoni M; Romani M
    Ann N Y Acad Sci; 2004 Dec; 1028():157-67. PubMed ID: 15650242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
    Shimada H; Nakagawa A; Peters J; Wang H; Wakamatsu PK; Lukens JN; Matthay KK; Siegel SE; Seeger RC
    Cancer; 2004 Oct; 101(8):1873-81. PubMed ID: 15386308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.